About us

Primary Packaging

The Primary Packaging evolution in the midst of new markets and innovations.

1989-2007: FROM ITS FIRST APPEARANCE ON THE MARKET TO ITS FIRST COMPLETE LINE.

The decade of 1980 to 1990 was marked by significant change. Similar to what we see today, the players leading the sector such as the German producers Groeninger or Bosch were joined by Italian and French companies. It was precisely when Steriline entered the Asian and Indian market in particular. A key moment arrived for Steriline starting from the early globalisation phases of companies and production process automation.

It was a moment that coincided with SFM’s entry to design and build filling machinery, and was concomitant with the installation of the first isolator lines on the Indian market. All of this allowed Steriline to pursue a path of all but exponential growth. All in all, it was an investment in terms of human resources and was important for the company at the technological level.

THE STATE OF RESEARCH & DEVELOPMENT YESTERDAY AND TODAY.

Today the context is different from that of the past: today we are witnessing a series of significant research and development investments. It is a context that has totally changed compared to when prototyping coincided with production, when the same resources had to follow two stages, whereas today Steriline has a completely dedicated department.

And yet once again the German market is an example, such as Bosch that demonstrates its commitment in the research and development sector by supplying products designed with very precise innovation criteria.

ROBOTICS AND PHARMA 4.0: HOW THE MARKET IS CHANGING.

Robotics represents a corporate, technological and cultural moment that is changing the paradigm market in terms of production approach. Today automation allows us to meet needs at the production customisation level in a framework of flexibility. In recent years, demands relating to the unconventional shape container process have increased and so the need for automation has consequently increased.

Steriline undoubtedly got off to a good start, ahead of its competitors, as regards this scenario. From filling nested syringes to vial machinery and up to a new, faster and better performing robotic steriliser model that sanctions the will to continue down the road of continuous innovation. We have taken the lead on this road in the 4.0 world as well, with the development of manuals and documentation in a scheduled intervention logic.

PRIMARY PACKAGING: AN OUTLOOK FOR THE FUTURE

One of the topics certainly not given appropriate importance in the past is that of sustainability. In the past, the pharmaceutical industry had always had an agenda in terms of priority in which environmental sustainability was not at the top of the list. Today the context has definitely changed, and fortunately Steriline has always had a sustainable outlook.

One example is the tunnel produced by Steriline that is one of the top performers from the performance/consumption viewpoint. And the consumption/performance ratio will be essential. In fact, guaranteeing a product that is the result of the best balance between performance and environmental impact will be crucial for all companies, and this applies to the pharmaceutical industry as well as many others.